Gennex Laboratories share news, announcements and annual reports

BSE: 531739Pharmaceuticals & BiotechnologySmall Cap

Gennex Laboratories Ltd · Face value ₹1 · Listed May 1996

₹8.96₹0.14 (1.54%)

Share price at the BSE close on 29 Oct 2026. Previous close ₹9.10.

29 Oct: open ₹9.20, high ₹9.20, low ₹8.91

52-week range of traded prices to 29 Oct 2026

₹7.05Low, 30 Mar 2026₹17.15High, 29 Oct 2025

Market cap: ₹218 Cr2,248th largest listed
P/E: 11.85
P/B: 0.98
Dividend yield: Nonein the last 12 months
ROE: 9.0%
ROCE: 7.0%
Debt to equity: 0.15
Volume, BSE: 1,88,622

Gennex Laboratories share news and announcements

553 announcements, routine notices left out, newest first. Page 9 of 12.

Jan 2019
- 8 Jan · Statement Of Investor Complaints For The Quarter Ended December 2018
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Nov 2018
- 14 Nov · Results
  We enclose the Standalone and Consolidated Un-Audited Financial Results as per Ind-AS for the 2nd Quarter and Half Year ended 30th September, 2018 of the Company together with Limited Review ....
- 6 Nov · Board meeting
  GENNEX LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2018 ,inter alia, to consider and approve we hereby inform you that ....
Oct 2018
- 31 Oct · Submission Of Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  With reference to the above captioned subject, we are enclosing herewith the certificate under Regulations 40(9) of SEBI (LODR) Regulations, 2015 for the period from 01st April 2018 to ....
- 31 Oct · Submission Of Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  With reference to the above captioned subject, we are enclosing herewith the certificate under Regulations 40(9) of SEBI (LODR) Regulations, 2015 for the period from 01st April 2018 to ....
- 26 Oct · Compliance Certificate Certifying Maintaining Physical & Electronic Transfer Facility. Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  In compliance with Regulation 7(3) of the above said Regulations, We file herewith the Compliance Certificate Certifying maintaining physical & electronic transfer facility for the Quarter ....
- 22 Oct · Statement Of Investor Complaints Redressal Mechanism Under Regulation 13(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  In compliance with Regulation 13(3) of the above said Regulations, We file herewith the statement of Investors Complaints for the Quarter ended 30th September, 2018 as provided by our RTA. ....
- 22 Oct · Statement Of Investor Complaints For The Quarter Ended September 2018
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 20 Oct · Shareholding for the Period Ended September 30, 2018
  Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click ....
Sep 2018
- 26 Sep · Consent for Establishment - Deccan Remedies Ltd
  Company's Associate Company namely, Deccan Remedies Limited has received Consent Order For Establishment - (CFE) issued by the Telangana ....
Aug 2018
- 14 Aug · Results
  This is to inform you that the Un-audited financial results for the quarter ended June 30, 2018 was approved and taken on records by the Board of Directors at their meeting held on August ....
- 13 Aug · Results
  Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
- 13 Aug · Meeting
  In accordance with the regulation 14 of SEBI (Listing Obligation and Disclosure Requirements), please find enclosed the voting results and Scrutinizer's Report on the Resolutions passed ....
- 9 Aug · Announcement under Regulation 30 (LODR)-Meeting Updates
  Pursuant to Regulation 30 Part A of Schedule III of SEBI(LODR) 2015, we are enclosing herewith the Summary of the Proceedings of the 31st Annual General Meeting of Gennex Laboratories ....
- 4 Aug · Board meeting
  GENNEX LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2018 ,inter alias, to consider and approve we hereby inform you ....
Jul 2018
- 21 Jul · Shareholding for the Period Ended June 30, 2018
  Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click ....
- 20 Jul · Statement Of Investor Complaints For The Quarter Ended June 2018
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 12 Jul · Corporate action
  As per provisions of Section 154 of the Companies Act, 1956 and according to Clause 15 & 16 of the Listing Agreement, we would like to inform you that the Register of Members and Share ....
- 6 Jul · Board meeting
  This is to inform you that the Board of Directors of the Company at its meeting held today, has decided to hold the Company's Annual General Meeting for the financial year, 2017-18 on Thursday ....
Jun 2018
- 22 Jun · Notice Of The Board Meeting To Be Held On Friday The 06Th July,2018 At 11.30 AM.
  We hereby give you notice that the meeting of Board of Directors of the Company will be held on Friday, the 06th July, 2018 at 11.30 A.M. at the Corporate Office of the Company situated ....
May 2018
- 31 May · "Form B" For The Year Ended 31 March 2018
  Please find attached 'Form B' (for Audit Report on modified opinion), as approved by the Board of Directors at its meeting held today in terms of Regulation 33(3)(d) of Securities and Exchange ....
- 30 May · Results
  Further to our letter dated.21.05.2018, in compliance with Regulation 30 and Regulation 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015, please find enclosed ....
- 21 May · Notice Of The Board Meeting To Be Held On Wednesday The 30Th May, 2018 At 11.30 A.M.
  We hereby inform you that the meeting of Board of Directors of the Company will be held on Wednesday the 30th May, 2018 at 11.30 A.M at the Corporate Office of the Company situated at 'Akash ....
- 12 May · Management
  Meeting of the Board of Directors of the Company has been held as scheduled at 11.30 a.m. today at the Corporate Office of the Company and the following Agenda was discussed and Resolutions ....
- 9 May · Notice Of The Board Meeting To Be Held On Saturday The 12Th May, 2018 At 11.30 A.M.
  We hereby inform you that the meeting of Board of Directors of the Company will be held on Saturday the 12th May, 2018 at 11.30 A.M at the Corporate Office of the Company situated at 'Akash ....
Apr 2018
- 30 Apr · Submission Of Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  With reference to the above captioned subject, we are enclosing herewith the certificate under Regulations 40(9) of SEBI (LODR) Regulations, 2015 for the period from 01st October, 2017 ....
- 21 Apr · Shareholding for the Period Ended March 31, 2018
  Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click ....
- 3 Apr · Statement Of Investor Complaints For The Quarter Ended March 2018
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0 <t
Feb 2018
- 14 Feb · Results
  This is to inform you that Un-Audited Financial Result for the 3rd Quarter Ended 31 December, 2017 was approved and taken on records by the Board of Directors at their meeting held on 14th ....
- 3 Feb · Results
  We hereby give you notice that the meeting of Board of Directors of the company ....
Jan 2018
- 22 Jan · Shareholding for the Period Ended December 31, 2017
  Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click ....
- 20 Jan · Statement Of Investor Complaints Redressal Mechanism Under Regulation 13(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  Scrip Code: 531739 Dear Sir/Madam, In compliance with Regulation 13(3) of the above said Regulations, We file herewith the statement of Investors Complaints for the quarter ....
Dec 2017
- 14 Dec · Results
  This is to inform you that the Un-audited financial results for the Second Quarter & Half Year Ended September 30, 2017 was approved and taken on record by the Board of Directors at their ....
- 5 Dec · Results
  We hereby give you notice that the meeting of Board of Directors of the ....
Oct 2017
- 31 Oct · September 2017
  This is to certify that, R&D Infotech Pvt. Ltd., is providing registry and share transfer services to Gennex Laboratories Limited a issuer Company
- 23 Oct · Submission Of Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  With reference to the above captioned subject, we are enclosing herewith the certificate under Regulations 40(9) of SEBI (LODR) Regulations, 2015 for the period from 01st April, 2017 to ....
- 21 Oct · Shareholding for the Period Ended September 30, 2017
  Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click ....
- 17 Oct · Meeting
  We are forwarding herewith a copy of Annual Report of the Company for the Financial Year 2016-17 as required under Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements), ....
- 14 Oct · Statement Of Investor Complaints Redressal Mechanism Under Regulation 13(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  In compliance with Regulation 13(3) of the above said Regulations, We file herewith the statement of Investors Complaints for the quarter ended 30th September, 2017 as provided by our RTA. ....
- 14 Oct · Statement Of Investor Complaints Redressal Mechanism Under Regulation 13(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  In compliance with Regulation 13(3) of the above said Regulations, We file herewith the statement of Investors Complaints for the quarter ended 30th September, 2017 as provided by our RTA. ....
- 14 Oct · Statement Of Investor Complaints Redressal Mechanism Under Regulation 13(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  In compliance with Regulation 13(3) of the above said Regulations, We file herewith the statement of Investors Complaints for the quarter ended 30th September, 2017 as provided by our RTA. ....
Sep 2017
- 30 Sep · Results
  Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
- 30 Sep · Meeting
  In accordance with the regulation 44(3) of SEBI (Listing Obligation and Disclosure Requirements) 2015, please find enclosed the voting results and Scrutinizer's Report on the resolutions ....
- 28 Sep · Meeting
  Pursuant to Regulation 30 Part A of Schedule III of SEBI (LODR), 2015, we are enclosing herewith the Summary of Proceedings of the 32nd Annual General Meeting of Gennex Laboratories Limited ....
- 14 Sep · Results
  This is to inform you that the Un-audited financial results for the quarter ended June 30, 2017 was approved and taken on record by the Board of Directors at their meeting held on September ....
- 6 Sep · Results
  We hereby give you notice that the meeting of Board of Directors of the company ....
Aug 2017
- 30 Aug · Corporate action
  As per provisions of Section 154 of the Companies Act, 1956 and according to Clause 15 & 16 of the Listing Agreement, we would like to inform you that the Register of Members and Share ....
- 29 Aug · Meeting
  Register of Members & Share Transfer Books of the Company will remain closed from September 23, 2017 to September 28, 2017 (both days inclusive) ....
- 26 Aug · Board meeting
  We are pleased to inform you the outcome of the meeting of Board of Directors of the Company held on Saturday, 26th August 2017 as follows: 1) The 32nd Annual General Meeting ....
- 18 Aug · Notice Of The Board Meeting To Be Held On Monday The 26Th August, 2017 At 11.30 AM.
  With reference to the above subject, we wish to inform you that a meeting of the Board of Directors of the Company will be held on Saturday, the 26th day of August, 2017, at 11.30 A.M. ....

Gennex Laboratories share news and announcements

Jan 2019

Nov 2018

Oct 2018

Sep 2018

Aug 2018

Jul 2018

Jun 2018

May 2018

Apr 2018

Feb 2018

Jan 2018

Dec 2017

Oct 2017

Sep 2017

Aug 2017